Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment: Viewpoints in dermatology • Correspondence

Clinical and Experimental Dermatology

Volumn 35, Issue 4, 2010, Pages

  O'Kane, D ^a   Devereux, C E ^a   Walsh, M Y ^a   Hoey, S E H ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; METHOTREXATE;

ADULT; CASE REPORT; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FOLLOW UP; HUMAN; HYPERKERATOSIS; LETTER; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; PARAKERATOSIS; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REMISSION; SKIN BIOPSY;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; MALE; PITYRIASIS RUBRA PILARIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77951212843     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03747.x     Document Type: Letter

References (5)

1. Drosou A, Kirsner RS, Welsh E et al. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 2003 7 : 382 386. (Pubitemid 37500396)
2. Ruiz-Genao DP, Lopez-Estebaranz JL, Naz-Villalba E et al. Pityriasis rubra pilaris successfully treated with infliximab. Acta Derm Venereol 2007 87 : 552 553. (Pubitemid 351373408)
3. Seckin D, Tula E, Ergun T. Successful use of etanercept in type I pityriasis rubra pilaris. Br J Dermatol 2008 158 : 642 644. (Pubitemid 351239177)
4. Davis KF, Wu JJ, Murase JE et al. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch Dermatol 2007 143 : 1597 1599.
5. Walling HW, Swick BL. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch Dermatol 2009 145 : 99 101.